Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Ciclosporin
Cequa
Routinely available
SMC (SMC2739)
05/02/2025
Indication
Treatment of moderate-to-severe Dry Eye Disease (keratoconjunctivitis sicca) in adult patients who have not responded adequately to artificial tears. SMC restriction: severe keratitis in adult patients with Dry Eye Disease.
Therapeutic Area
Eye
Status Description
Routinely available in line with national guidance
Formulation
0.9 mg/mL eye drops, solution in single-dose container
Comments
Link to Advice
Advice Published
13/01/2025
SMC Submission Type
Abbreviated
SMC Status
Restricted